A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Status Completed

Clinical Trial Summary

CG53135-05 (velafermin), a recombinant human fibroblast growth factor-20 (rhFGF-20) protein, is under investigation for the prevention of oral mucositis. Oral mucositis is a commonly occurring side effect of high-dose chemotherapy in patients undergoing autologous hematopoietic stem cell transplant. The objective of this Phase II trial is to confirm the safety and efficacy of CG53135-05 (velafermin) when administered as a single dose to patients at risk for developing oral mucositis.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00323518
Study type	Interventional
Source	Celldex Therapeutics
Contact
Status	Completed
Phase	Phase 2
Start date	May 2006
Completion date	August 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02229136` - Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus	Phase 2
Terminated	`NCT03843554` - Commensal Oral Microbiota in Head and Neck Cancer	N/A
Enrolling by invitation	`NCT02662374` - Oral Hygiene Regimen in Patients on HCT	Phase 4
Completed	`NCT00938080` - Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck	Phase 1
Completed	`NCT00756951` - Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer	Phase 2
Completed	`NCT00701688` - Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation	Phase 1
Not yet recruiting	`NCT05059613` - Thalidomide With or Without Probiotics in Radioactive Oral Mucositis	N/A
Completed	`NCT04440930` - White Tea for Prevention of Chemotherapy Induced Mucositis	N/A
Completed	`NCT05705622` - The Effect of Nursing Education on Oral Mucositis in Bone Marrow Transplant Patients	N/A
Completed	`NCT02399228` - A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis	Phase 2
Withdrawn	`NCT02589860` - Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant
Active, not recruiting	`NCT01772706` - Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer	N/A
Enrolling by invitation	`NCT06122636` - Efficacy of a Probiotic and Microbiological Analysis on Oral Complications Induced by Antineoplastic Therapies in Patients With HNC	N/A
Completed	`NCT03689712` - ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients	Phase 3
Terminated	`NCT02539342` - Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy	Phase 3
Completed	`NCT02555501` - Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy	Phase 3
Completed	`NCT01789658` - Cryotherapy for Prevention of Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation	N/A
Completed	`NCT00790322` - Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy	Phase 3
Recruiting	`NCT00549952` - Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients	N/A
Completed	`NCT00289003` - The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients	Phase 2